Research on oral peptide delivery consistently points to formulation design as the key factor in how much of the compound survives the digestive process
As we noted in a recent update and earlier this year, telehealth companies, compounding pharmacies, medspas and other businesses promoting, manufacturing or facilitating access to compounded GLP-1 drugs should audit their advertising practices to take into account recent challenges and FDA activity
GSSG does not possess the same oxidation regulating effects that reduced glutathione does
Reducing CXCL9 enables senescent endothelial cells to restore function
10.1007/s00421-015-3170-4
If not closely managed, this can lead to side effects such as joint pain, fluid retention, insulin resistance, and other concerns